Every S-1 that Vivakor, Inc. (VIVK) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A S-1 covers the registration statement a company files to sell shares publicly, so if you follow VIVK and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VIVK filings page.
Vivakor, Inc. filed an amended registration statement covering the resale of up to 40,686,375 shares of common stock by existing selling stockholders. This includes 40,540,542 shares issuable on conversion of $15,000,000 of convertible promissory notes and 145,833 already outstanding shares.
The company will not receive proceeds from these resales, though it previously raised up to $12.0 million in gross proceeds from the notes and entered a separate $100 million Standby Equity Purchase Agreement for potential future equity sales. Vivakor highlights an accumulated deficit near $205 million, an auditor going‑concern explanatory paragraph, and states it is currently in an unsound financial condition, while also warning of significant dilution risk from outstanding convertible notes and other equity-linked instruments.
Vivakor, Inc. is registering 40,686,375 shares of common stock for resale by existing investors. The shares consist mostly of 40,540,542 shares issuable from $15 million of convertible notes plus 145,833 already outstanding shares. Vivakor will not receive any proceeds from these resales; selling stockholders will receive all net proceeds.
The company recently completed a 1‑for‑200 reverse stock split and had 4,295,647 shares outstanding as of May 22, 2026, which would rise to 44,982,022 shares if all registered shares are issued. Vivakor describes itself as in an unsound financial condition, with an accumulated deficit of about $205 million, going‑concern doubts from auditors, heavy dependence on volatile oil markets, customer and geographic concentration, and significant potential dilution from convertible debt and a separate standby equity facility of up to $100 million.
Vivakor, Inc. is registering up to 40,686,375 shares of common stock for resale by existing investors, mainly shares issuable on conversion of $15,000,000 of convertible promissory notes, and will not receive proceeds from these sales. As of May 14, 2026, Vivakor had 4,246,759 common shares outstanding, which would rise to 44,787,301 shares if all shares covered here are issued. The notes convert at the higher of a $0.37 floor price or 80% of the recent volume-weighted average price and are subject to beneficial ownership and Nasdaq issuance limits. Vivakor discloses an accumulated deficit of about $205 million, a going concern warning, and describes itself as in an unsound financial condition, while also highlighting significant prior midstream acquisitions, asset impairments tied to Kuwait remediation units, and new financing tools including the convertible notes and a standby equity purchase agreement of up to $100 million.